The diagnostic value of blood metagenomic next-generation sequencing in patients with acute hematogenous osteomyelitis

AimsThis study aims to evaluate the diagnostic value of blood metagenomic next-generation sequencing (mNGS) in detecting pathogens from patients clinically diagnosed as acute hematogenous osteomyelitis (AHO).MethodsThis retrospective study enrolled 66 patients with AHO. The test results of mNGS and...

Full description

Bibliographic Details
Main Authors: Bingshi Zhang, Xiao Chen, Xiaowei Yao, Mengnan Li, Zhijie Li, Bo Liu, Sikai Liu, Zeming Liu, Jia Huo, Yongtai Han
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2023.1106097/full
_version_ 1797942041433341952
author Bingshi Zhang
Xiao Chen
Xiaowei Yao
Mengnan Li
Zhijie Li
Bo Liu
Sikai Liu
Zeming Liu
Jia Huo
Yongtai Han
author_facet Bingshi Zhang
Xiao Chen
Xiaowei Yao
Mengnan Li
Zhijie Li
Bo Liu
Sikai Liu
Zeming Liu
Jia Huo
Yongtai Han
author_sort Bingshi Zhang
collection DOAJ
description AimsThis study aims to evaluate the diagnostic value of blood metagenomic next-generation sequencing (mNGS) in detecting pathogens from patients clinically diagnosed as acute hematogenous osteomyelitis (AHO).MethodsThis retrospective study enrolled 66 patients with AHO. The test results of mNGS and bacterial culture on different samples, including blood and puncture fluid samples, from patients with AHO were compared to explore the diagnostic value of blood mNGS. Besides, this study also explored the efficacy of blood mNGS in decision making for antibiotic administration and analyzed the factors associated with the positive result of blood mNGS.ResultsThe most common causative pathogens were Staphylococcus and Streptococcus. The sensitivity of blood mNGS (77.3%) was higher than that of blood culture (42.4%) (P<0.001), while the turnaround time of blood mNGS (2.1 ± 0.4 d) is much less than that of blood culture (6.0 ± 2.1 d) (P<0.001). Besides, the sensitivity of blood mNGS tests (77.3%) was slightly lower than that of puncture fluid mNGS (89.4%). Furthermore, detection comparison at pathogen level unravels that blood mNGS might be suitable for diagnosing AHO caused by common pathogens, while puncture fluid mNGS could be considered as preferred examination in diagnosing AHO caused by uncommon pathogens. Finally, three independent factors associated with the true positive result of blood mNGS in patients with AHO were identified, including Gram-positive pathogens (OR=24.4, 95% CI = 1.4-421.0 for Staphylococcus; OR=14.9, 95%CI= 1.6-136.1 for other Gram-positive bacteria), body temperature at sampling time (OR=8.2, 95% CI = 0.6-107.3 for body temperature of >38.5°C; OR=17.2, 95% CI = 2.0-149.1 for patients who were chilling), and no use of antibiotics before sampling (OR=8.9, 95% CI =1.4-59.0).ConclusionThis is the first report on evaluating and emphasizing the importance of blood mNGS in diagnosing AHO. Blood sample might be an alternative sample for puncture fluid for mNGS, and its extensive application in diagnosing AHO could be expected.
first_indexed 2024-04-10T20:01:22Z
format Article
id doaj.art-569744c34c11481daa4814bb90b7e8ed
institution Directory Open Access Journal
issn 2235-2988
language English
last_indexed 2024-04-10T20:01:22Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj.art-569744c34c11481daa4814bb90b7e8ed2023-01-27T05:13:43ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882023-01-011310.3389/fcimb.2023.11060971106097The diagnostic value of blood metagenomic next-generation sequencing in patients with acute hematogenous osteomyelitisBingshi Zhang0Xiao Chen1Xiaowei Yao2Mengnan Li3Zhijie Li4Bo Liu5Sikai Liu6Zeming Liu7Jia Huo8Yongtai Han9Department of Osteonecrosis and Hip Surgery, The Third Hospital of Hebei Medical, Shijiazhuang, Hebei, ChinaDepartment of Osteonecrosis and Hip Surgery, The Third Hospital of Hebei Medical, Shijiazhuang, Hebei, ChinaDepartment of Orthopedics, The Chest Hospital of Hebei Province, Shijizhuang, Hebei, ChinaDepartment of Osteonecrosis and Hip Surgery, The Third Hospital of Hebei Medical, Shijiazhuang, Hebei, ChinaOrthopedics Department, Affiliated Hospital of Hebei Engineering University, Handan, Hebei, ChinaDepartment of Osteonecrosis and Hip Surgery, The Third Hospital of Hebei Medical, Shijiazhuang, Hebei, ChinaDepartment of Osteonecrosis and Hip Surgery, The Third Hospital of Hebei Medical, Shijiazhuang, Hebei, ChinaDepartment of Osteonecrosis and Hip Surgery, The Third Hospital of Hebei Medical, Shijiazhuang, Hebei, ChinaDepartment of Osteonecrosis and Hip Surgery, The Third Hospital of Hebei Medical, Shijiazhuang, Hebei, ChinaDepartment of Osteonecrosis and Hip Surgery, The Third Hospital of Hebei Medical, Shijiazhuang, Hebei, ChinaAimsThis study aims to evaluate the diagnostic value of blood metagenomic next-generation sequencing (mNGS) in detecting pathogens from patients clinically diagnosed as acute hematogenous osteomyelitis (AHO).MethodsThis retrospective study enrolled 66 patients with AHO. The test results of mNGS and bacterial culture on different samples, including blood and puncture fluid samples, from patients with AHO were compared to explore the diagnostic value of blood mNGS. Besides, this study also explored the efficacy of blood mNGS in decision making for antibiotic administration and analyzed the factors associated with the positive result of blood mNGS.ResultsThe most common causative pathogens were Staphylococcus and Streptococcus. The sensitivity of blood mNGS (77.3%) was higher than that of blood culture (42.4%) (P<0.001), while the turnaround time of blood mNGS (2.1 ± 0.4 d) is much less than that of blood culture (6.0 ± 2.1 d) (P<0.001). Besides, the sensitivity of blood mNGS tests (77.3%) was slightly lower than that of puncture fluid mNGS (89.4%). Furthermore, detection comparison at pathogen level unravels that blood mNGS might be suitable for diagnosing AHO caused by common pathogens, while puncture fluid mNGS could be considered as preferred examination in diagnosing AHO caused by uncommon pathogens. Finally, three independent factors associated with the true positive result of blood mNGS in patients with AHO were identified, including Gram-positive pathogens (OR=24.4, 95% CI = 1.4-421.0 for Staphylococcus; OR=14.9, 95%CI= 1.6-136.1 for other Gram-positive bacteria), body temperature at sampling time (OR=8.2, 95% CI = 0.6-107.3 for body temperature of >38.5°C; OR=17.2, 95% CI = 2.0-149.1 for patients who were chilling), and no use of antibiotics before sampling (OR=8.9, 95% CI =1.4-59.0).ConclusionThis is the first report on evaluating and emphasizing the importance of blood mNGS in diagnosing AHO. Blood sample might be an alternative sample for puncture fluid for mNGS, and its extensive application in diagnosing AHO could be expected.https://www.frontiersin.org/articles/10.3389/fcimb.2023.1106097/fulldiagnostic testmetagenomic next-generation sequencing (mNGS)infectionosteomyelitis (OM)blood
spellingShingle Bingshi Zhang
Xiao Chen
Xiaowei Yao
Mengnan Li
Zhijie Li
Bo Liu
Sikai Liu
Zeming Liu
Jia Huo
Yongtai Han
The diagnostic value of blood metagenomic next-generation sequencing in patients with acute hematogenous osteomyelitis
Frontiers in Cellular and Infection Microbiology
diagnostic test
metagenomic next-generation sequencing (mNGS)
infection
osteomyelitis (OM)
blood
title The diagnostic value of blood metagenomic next-generation sequencing in patients with acute hematogenous osteomyelitis
title_full The diagnostic value of blood metagenomic next-generation sequencing in patients with acute hematogenous osteomyelitis
title_fullStr The diagnostic value of blood metagenomic next-generation sequencing in patients with acute hematogenous osteomyelitis
title_full_unstemmed The diagnostic value of blood metagenomic next-generation sequencing in patients with acute hematogenous osteomyelitis
title_short The diagnostic value of blood metagenomic next-generation sequencing in patients with acute hematogenous osteomyelitis
title_sort diagnostic value of blood metagenomic next generation sequencing in patients with acute hematogenous osteomyelitis
topic diagnostic test
metagenomic next-generation sequencing (mNGS)
infection
osteomyelitis (OM)
blood
url https://www.frontiersin.org/articles/10.3389/fcimb.2023.1106097/full
work_keys_str_mv AT bingshizhang thediagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT xiaochen thediagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT xiaoweiyao thediagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT mengnanli thediagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT zhijieli thediagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT boliu thediagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT sikailiu thediagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT zemingliu thediagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT jiahuo thediagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT yongtaihan thediagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT bingshizhang diagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT xiaochen diagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT xiaoweiyao diagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT mengnanli diagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT zhijieli diagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT boliu diagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT sikailiu diagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT zemingliu diagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT jiahuo diagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT yongtaihan diagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis